Semiconductor & Electronics Technology

Monday, 20 August 2018

Globle Blood Glucose Monitoring System Market : Size, Application, Statistics, Companies Poised for Strong Growth in Future by 2024

The global blood glucose monitoring system market is growing at significant rate due to increasing prevalence of diabetes. The market is expected to grow at the faster rate for continuous blood glucose monitoring products in the coming years due to increasing adoption of minimally invasive procedure.

Download Free Report Sample Copy: https://www.vynzresearch.com/healthcare/blood-glucose-monitoring-system-market/request-sample

There are two types of blood glucose monitoring system, self-monitoring blood glucose systems and continuous monitoring blood glucose system. Of both the types the continuous monitoring blood glucose system market is expected to grow at the higher growth rate, due to increasing adoption of minimally invasive procedure.

The high cost of blood glucose monitoring products, invasiveness of blood glucose monitors and poor reimbursement of blood glucose monitoring devices and supplies are the major challenges for the growth of blood glucose monitoring system market. In developing countries it is difficult to bear the cost of the testing strips and blood glucose monitors due to poor reimbursement policies. Moreover, in some of the developed countries in Europe and in Canada, the limitation on the supply of testing strips per patient hinder the growth of the market.

The strong distribution channel for blood glucose monitoring products helps to cater the increasing demand of diabetic care device. The key challenge for the new entrants is the survival in capital intensive and highly regulated blood glucose monitoring system market.

Explore Full Report Description at: https://www.vynzresearch.com/healthcare/blood-glucose-monitoring-system-market

Geographically, North America is the largest blood glucose monitoring system market as the region has favorable reimbursement policies, increasing awareness program and rising FDA approvals. Increasing prevalence of diabetes has fueled the growth of the North American blood glucose monitoring system market. For instance, according to Centers for Disease Control and Prevention (CDC), in 2015, approximately 23.1 million people in the U.S. had diabetes.

Key players in the blood glucose monitoring system market are investing in the development of innovative and advance products, which is strengthening their position in the market. In September 2016, Abbott gained FDA approval for the FreeStyle Libre Pro continuous glucose monitoring (CGM) device, a professional-use device to provide better diabetes management to diabetes patient. In addition, in August 2016, Roche launched the Accu-Chek Guide, the next-generation blood glucose monitoring system. Abbott Laboratories, B. Braun Melsungen, F. Hoffmann-La Roche, Ypsomed, Lifescan, Medtronic, Ascensia Diabetes Care, Dexcom, Nipro and Sanofi are the key players offering blood glucose monitoring products.

About VynZ Research :

VynZ Research is an innovative market research and competitive intelligence company with global competences. We have helped several customers to develop their strategy and make better business decisions by providing actionable intelligence through market research report.

Contact

VynZ Research USA

165 Broadway, 23rd Floor,
New York City, New York – 10006
United States of America
Toll-Free:1-888-253-3960
Website: https://www.vynzresearch.com
Email: support@vynzresearch.com
Connect With us: Linkedin | Twitter |Google | Facebook

Tuesday, 7 August 2018

North America is the Largest Tumor Ablation Market Due to the Mounting Occurrence of Cancer

Ablation is the method to destroy tumor without removing it, which is used in patients with few small tumors, when surgery is not preferred. The global tumor ablation market is growing at a significant rate due to increasing prevalence of cancer, and rapid growth in geriatric population. Different types of technology contributed to the tumor ablation industry size. The market has witnessed extreme demand for radiofrequency ablation over the last few years, due to easiness of treatment and continuing growths of technologically innovative radiofrequency tumor ablation.

Get Free Report Sample Copy at:https://www.vynzresearch.com/healthcare/tumor-ablation-market/request-sample

The global tumor ablation market has also been subdivided by application into liver cancer, bone metastasis, lung cancer, kidney cancer and others. Liver cancer segment hold the major share in the market due to mounting occurrence of liver cancer. For instance, according to GLOBOCAN, liver cancer is the second most common cause of death from cancer globally, approximately 746,000 deaths occurred due to liver cancer in 2012. Moreover, lung cancer is expected to grow at the fastest rate due to escalating air pollution, boosting rate of smoking and sedentary lifestyle. For instance, according to GLOBOCAN globally approximately 1.8 million new lung cancer cases were diagnosed in 2012.

The rapid expanding aging population, escalating occurrence of cancer, and technological improvement in ablation devices are the primary growth drivers for tumor ablation market. For instance, according to GLOBOCAN globally approximately 14.1 million new cancer cases were diagnosed and there were 8.2 million cancer deaths in 2012. In addition, according to World Health Organization (WHO), in 2015 approximately 8.8 million people died due to cancer. Moreover, approximately 70% of the deaths from cancer occur in low and middle income countries.

Explore Full Report Description at: https://www.vynzresearch.com/healthcare/tumor-ablation-market

The cost reserve procedures taken by various governments, strict regulatory requirements of product introduction, and adverse regulatory strategies in the U.S. are the major challenges for the growth of tumor ablation market.

Geographically, North America is the largest tumor ablation market due to the mounting occurrence of cancer, boosting government funding for cancer research, expanding geriatric population and intensifying need for minimally invasive procedure for cancer treatment. For instance, according to GLOBOCAN in the U.S. approximately 1.6 million new cancer cases were diagnosed and there were 0.6 million cancer deaths in 2012.

Asia-Pacific is observed to witness the fastest growth in the market as the region comprises of largest population. In addition, growing medical tourism, expanding geriatric population, boosting government initiates for reconstruction of healthcare infrastructure and minimally invasive surgical procedures are also creating a positive impact on the tumor ablation market growth in the region.

Key players in the industry are investing in the development of innovative and advance ablation products, which is strengthening their position in the market. In April 2018, Medtronic launched OptiShere embolization sphere designed for embolization of hypervascular tumors in the U.S.

In addition, in April 2018 Medtronic launched the Visualase MRI-Guided Laser Ablation System, to provide advanced MRI-guided laser ablation technology in the Europe. Medtronic, PLC, Angiodynamics, Inc., Healthtronics, Inc., Galil Medical, Inc., Boston Scientific Corporation, Neuwave Medical, Inc., Edap Tms S.A., Mermaid Medical A/S, Sonacare Medical, LLC, and Misonix, Inc. are some of the key players offering ablation products.

About VynZ Research:

VynZ Research is a global market intelligence company providing research reports, industry intelligence and business advisory services to companies and institutions across the globe. We have a recognized trajectory record and our research database is used by many renowned companies and institutions in the world to strategize and revolutionize business opportunities. The company focuses on providing valuable insights on various technology verticals such as chemical and materials, automotive and transportation, energy and power, consumer goods, healthcare, ICT and other emerging technologies.

Contact

VynZ Research USA

Monday, 6 August 2018

Europe is the Largest Single-Use Bioreactor Market as the Government in the Region Supports for New Biologics

Single-use bioreactor (SUB) is used for the production of biopharmaceutical products due to its high performance and flexibility in the production of multiple drugs. It is mainly used in research and development and manufacturing of biopharmaceuticals. The global single-use bioreactor market is growing at significant rate due to growing biologic market, patent expiry of products and reduced automation complexity. The market has witnessed high demand for single-use bioreactor systems over the last few years, due to its advantages such as elimination of validation issues and shortened down time.

Get Free Report Sample Copy at: https://www.vynzresearch.com/healthcare/single-use-bioreactor-market/request-sample

The global single-use bioreactor market has also been segmented by type of cell into bacterial cell, yeast cell, mammalian cell and others. The mammalian cell segment is estimated to account largest share and is expected to grow at fastest rate in the market due to increasing application of mammalian cell in biologics manufacturing due to its high therapeutic efficiency.

The different types of molecule single-use bioreactor market is segmented into are vaccines, gene-modified cells, monoclonal antibodies, stem cell and other molecules. The monoclonal antibodies are estimated to account the largest share in the market due to increase in demand for SUB system which provides greater productivity and flexibility, less requirement of manpower and low investment cost.

The single-use bioreactor market has also been segmented by application into research and development, bioproduction process and process development. The bioproduction process segment is estimated to account largest share in the market due to increasing adoption of SUB system due to its easy implementation and low investment cost.

Explore Full Report Description at: https://www.vynzresearch.com/healthcare/single-use-bioreactor-market

Moreover, growing biologics market, reduced automation complexity, and ease in cultivation of marine organisms are also fueling the growth of the global single-use bioreactor market. Automation of stainless steel system and single-use systems differs in complexity. Stainless-steel reactors need a continuous cleaning and sterilization which results in a high consumption of chemicals and ultrapure water.

In addition, technological advancement in SUB is also boosting the growth of the single-use bioreactor industry. For instance, manufacturers are focusing on introducing high-power SUB and the control systems are also being improved to help in multiple unit operations. New systems are also being designed specifically for microbial fermentation. Moreover, improvement in the design, sensor system, and film technology of bioreactor is also increasing adoption of SUB.Geographically, Europe is the largest single-use bioreactor market as the government in the region supports for new biologics. Some of the other factors leading to the growth of the European market are growing research activities, reduced environmental impact, technological advancement, patent expiry of products, and increasing adoption of SUB systems.

Asia-Pacific is observed to witness fastest growth in the market. Growing biologics market and increasing use of SUB in small and startup companies are the primary factors boosting the growth of the market. Moreover, growing research activities and reduced automation complexity are also driving the growth of the Asia-Pacific market.

Key players in the industry are investing in the development of innovative and advance products, which is strengthening their position in the market. On March 2018, WuXi Biologics announced that it has selected ABEC’s Custom Single Run disposable bioreactors for its new commercial manufacturing facility in Wuxi city, China. Sartorius Stedim Biotech, Eppendorf, Merck Millipore, Cesco Bioengineering, GE Healthcare, Applikon Biotechnology, Danaher, Thermo Fisher Scientific, Parker Hannifin, Cellexus and Celltainer Biotech are some of the key players offering single-use bioreactor.

About VynZ Research :

Contact

VynZ Research USA

Global Blood Glucose Monitoring System Market Research Report, Growth, Analysis and Forecast (2018-2024)

Diabetes mellitus is the group of chronic endocrine disorder due to insufficient level of insulin. Prolonged hyperglycemia (high blood sugar) can lead to severe complications including cardiovascular disease, kidney failure, diabetic retinopathy or nephropathy, and ulcers. Blood glucose monitoring systems are used for the testing of blood glucose level in the body. The global blood glucose monitoring system market is growing at significant rate due to increasing prevalence of diabetes. The market is expected to grow at the faster rate for continuous blood glucose monitoring products in the coming years due to increasing adoption of minimally invasive procedure.

Download Free Report Sample at: https://www.vynzresearch.com/healthcare/blood-glucose-monitoring-system-market/request-sample

On the basis of testing site, the blood glucose monitoring system market is segment into fingertip testing and alternate site testing. Fingertip testing is the most common technique used for measurement of blood glucose level. Fingertip testing segment has the larger share and is also expected to grow at the faster rate due to high reliability and accuracy of fingertip testing.

The global blood glucose monitoring system market has also been segmented by application into type I, type II and gestational diabetes. Type I diabetes accounts for about 5 to 10 percent of the diabetes cases and type II accounts for approximately 90 percent of the diabetic cases. Many patients with type II diabetes are asymptomatic. The type II diabetes segment is estimated to have largest share in the market due to increasing incidence of type II diabetes and increasing innovative product launches with less invasive technologies. For instance, according to International Diabetes Federation (IDF) in 2017 approximately 352 million people were at risk of developing type II diabetes.

Explore Full Report Description at: https://www.vynzresearch.com/healthcare/blood-glucose-monitoring-system-market

The high cost of blood glucose monitoring products, invasiveness of blood glucose monitors and poor reimbursement of blood glucose monitoring devices and supplies are the major challenges for the growth of blood glucose monitoring system market. In developing countries it is difficult to bear the cost of the testing strips and blood glucose monitors due to poor reimbursement policies. Moreover, in some of the developed countries in Europe and in Canada, the limitation on the supply of testing strips per patient hinder the growth of the market.

Asia-Pacific is observed to witness the fastest growth in demand for blood glucose monitoring products. Increasing prevalence of diabetes, increasing awareness of diabetes, increasing healthcare expenditure, and large population base are creating a positive impact on the blood glucose monitoring systems market growth in the region.

About VynZ Research :

Contact

VynZ Research USA

Saturday, 4 August 2018

North America is the Largest Clinical trial Imaging Market as in the Region the Research and Development Spending is Huge Analysis and Forecast to 2024

Clinical trial imaging is a component of massive research and development of biotechnology and pharmaceutical industries and drug development process. It helps in making trial more effective and accurate. The global clinical trial imaging market is growing at significant rate, due to mounting research and development spending by growing biotechnology and pharmaceutical industries and boosting number of contract research organization (CROs). Different products and services contributed to the clinical trial imaging market size. The market has witnessed high demand for services segment over the last few years due to elevated price of the imaging equipment.

Download Free Report Sample at: https://www.vynzresearch.com/healthcare/clinical-trial-imaging-market/request-sample

The mounting research and development spending by growing biotechnology and pharmaceutical industries, expansion in pharmaceutical and biotechnology industries and boosting number of CROs are the primary growth drivers for clinical trial imaging market. The pharmaceutical and biopharmaceutical companies are investing profoundly in the research and development for the advancement of new drugs. In the clinical research and life science sector, the organizations are attempting to invent and improve treatment for health problems, such as AIDS, diabetes, and cancer.

Expansion of advanced imaging modalities, and radiopharmaceuticals and mounting clinical research in emerging economies are also facilitating the growth for the clinical trial imaging market. The frequency of clinical research is mounting in the emerging economies, due to low operational cost, availability of large number of patients, faster recruitment rates, and availability of CRO’s focused on global trials.

Explore Full Report Description at: https://www.vynzresearch.com/healthcare/clinical-trial-imaging-market

The excessive cost of clinical trials, high employment price of imaging systems and elevated cost of positron emission tomography are the major challenges for the growth of clinical trial imaging market. High investment is involved in the drug development process in clinical trials. Moreover, it requires skilled labor for data collection, assessment, and maintaining records.

Globally, the manufacturing companies trying to enter the clinical trial imaging market are required to maintain stringent regulatory standards. Moreover, the high level of capital requirement also poses a major barrier for the entry of new players. This offers an edge to the established players in the industry competition.

Geographically, North America is the largest clinical trial imaging market as in the region the research and development spending is huge. Mounting number of pharmaceutical and biotechnology companies, and expanding number of CROs are also up surging growth of the North American clinical trial imaging market.

Asia-Pacific is observed to witness fastest growth in the market, as in the region number of biotechnology and pharmaceutical companies are increasing. In addition, mounting research and development spending is also creating a positive impact on the clinical trial imaging market growth in the region.

Key players in the clinical trial imaging market are catering the demand of these devices by investing on technologically advanced products in their product portfolio across the globe. In July 2017, ICON plc acquired Mapi Group to strengthen its commercialization and outcome research business. Parexel International Corporation, Radiant Sage LLC, ICON Plc, Biomedical Systems Corporation, Biotelemetry, Inc., Intrinsic Imaging LLC, Cardiovascular Imaging Technologies, LLC, Ixico PLC, and Worldcare Clinical, LLC are the key players offering clinical trial imaging.

Contact

VynZ Research USA

Friday, 3 August 2018

North American Market are Expanding Network of Stem Cell Banking Services, Size, Growth, Analysis and Forecast to 2024

Stem cell banking is the method of accumulating cord blood, extorting and cryogenically freezing its stem cells for forthcoming use. Cord blood stem cells are used for treating blood diseases such as sickle cell disease, leukemia and thalassemia. The global stem cell banking market is growing at significant rate due to development of novel technologies of storage, preservation and processing. The market has witnessed high demand for placenta stem cells over the last few years, due to the increasing public awareness regarding the therapeutic prospective of stem cells.

Get Free Report Sample at: https://www.vynzresearch.com/healthcare/stem-cell-banking-market/request-sample

The strict regulatory framework and high operational and processing costs are the major challenges for the growth of stem cell banking market. Moreover, the socio-ethical issues involved in stem cell research such as destruction of human embryo and religious briefs are considered as the hindering factor for the market.

The major challenge for the new competitors is the existence in capital intensive and highly regulated stem cell banking market. Moreover, the competition among the players is also high due to less product differentiation.

Explore Full Report Description at: https://www.vynzresearch.com/healthcare/stem-cell-banking-market

Geographically, North America is the largest stem cell banking market. Some of the other factors leading to the growth of the North American market are expanding network of stem cell banking services, technological advancement in the field of stem cell preservation and collection technique, availability of federal funding for research, and ongoing approval of stem cell lines for various disease treatments. Moreover, growing number of stem cell transplantation procedure and growing public-private investments for stem cell researches, and increasing public preference for private stem cell banks over public stem cell banks are also driving the growth of the North American stem cell banking market.

Asia-Pacific is observed to witness fastest growth in the market. As the region comprises of largest population and the awareness for stem cell banking is increasing rapidly among them. In addition, increasing awareness on the therapeutic potential of stem cells, improving healthcare infrastructure are also creating a positive impact on the stem cell banking market growth in the region.

Key players in the stem cell banking industry are investing in the development of innovative and advance products, which is strengthening their position in the market. In May 2018, Cordlife launched PlumCare DNA Advisor, to detect and manage genetic mutations associated with hereditary conditions in the Philippines. In addition, in December 2017, Cordlife had partnered with Eone-Diagnomics Genome Center (EDGC), a certified laboratory in South Korea, to offer non-invasive prenatal testing in Indonesia and the Philippines.

Cord Blood Registry Systems, Cordlife Group Limited, Cryo-Cell International, Cryo-Save AG, LifeCell International, StemCyte, ViaCord, Global Cord Blood, Smart Cells International, Vita34, and CryoHoldco are some of the key players offering products.

Contact

VynZ Research USA

Global Stem Cell Therapy Market has also been Segmented by Cell Source into Adipose Tissue-Derived Mesenchymal Stem Cell Analysis and Forecast to 2024

Stem cells are the basic cells of the body which are used to replace or repair patients cells and are responsible for organ growth and repair and wound healing. The global stem cell therapy market is growing at significant rate due to growing awareness regarding therapeutic potency of stem cells and development of infrastructure related to stem cell banking and processing. The market has witnessed high demand for allogenic therapies over the last few years, due to easy production scale-up process, and increasing commercialization of allogeneic therapy products.

Download Free Report Sample at: https://www.vynzresearch.com/healthcare/stem-cell-therapy-market/request-sample

The growing awareness related to the therapeutic potency of stem cells, development of infrastructure related to stem cell banking and processing, development of advanced genome-based cell analysis techniques, and increasing private-public investment for the development of stem cell therapies are the primary growth drivers for stem cell therapy market. According to the World Health Organization (WHO) globally, more than 50,000 transplants are carried out annually and it is increasing each year.

Moreover, restrictions of traditional organ transplantation such as dependence on organ donor, the threat of infection, rejection, and immunosuppression threat and increasing pipeline and development of drugs for emerging applications are also boosting the growth of the stem cell therapy market.

Explore Full Report Discription at: https://www.vynzresearch.com/healthcare/stem-cell-therapy-market

The technical limitations related to production scale-up, socio-ethical issues related to the use of stem cell in disease treatment and research and unclear regulatory guidelines for product development & commercialization are the major challenges for the growth of stem cell therapy market. The socio-ethical issues involved in stem cell research such as religious briefs and destruction of human embryo are considered as the hindering factor for the adaptation of stem cell therapy by the patient.

Moreover, high cost of research, less developed research infrastructure for stem cell therapies and storage of stem cell, difficulty related with the preservation of stem cell, and strict regulations to conduct trials on human are also hindering the growth of the stem cell therapy market.

The key encounter for the new entrants is the subsistence in capital demanding and highly regulated stem cell therapy market. Moreover, the competition among the players also increases due to less product differentiation.

Geographically, North America is the largest stem cell therapy market and is observed to witness the fastest growth in the market. Some of the factors leading to the growth of the North American stem cell therapy market are increasing number of clinical trials to evaluate therapeutic potential of products, increasing prevalence of chronic diseases, the growing patient base for target diseases, growing public awareness related to the therapeutic potency of therapy, and increasing public-private funding & research grants for developing safe and effective stem cell therapy products.

Major players in the industry are capitalizing in the development of technologically inventive and advance products, which is strengthening their position in the stem cell therapy market. In March 2017, Osiris Therapeutics launched Prestige Lyotechnology, a method for storage of living cells and tissues. In addition, in February 2018, MEDIPOST announced that FDA has approved its stem cell-based Alzheimer’s disease drug, NEUROSTEM for clinical trials. Osiris Therapeutics, Inc., RTI Surgical, Inc., MEDIPOST Co., Ltd., Nuvasive, Inc., Pharmicell Co., Ltd., Holostem Terapie Avanzate Srl, JCR Pharmaceuticals Co., Ltd., Anterogen Co., Ltd., and Allosource are some of the key players offering stem cell therapy products.

Contact

VynZ Research USA